Kalbe, a leader in healthcare spanning pharmaceuticals and nutrition, has been present in Sri Lanka for over 30 years, ...

Illicit drug use in Sri Lanka indicates a significant shift in consumption patterns from cannabis as the predominant drug consumed, particularly by those residing in urban townships to ...

Shares of Dr Reddy's Laboratories Ltd. and OneSource Specialty Pharma Ltd. declined up to 3% on Monday, June 2, after the Delhi High Court on Friday restrained the companies from selling semaglutide ...

Combining semaglutide with muscle-preserving antibodies protected lean mass – sparing approximately 50%-80% of the lean mass lost with semaglutide alone – while also increasing loss of fat ...

Speaking at the event, Chairperson of the John Keells Group, Krishan Balendra said, “BYD’s early success in Sri Lanka’s NEV segment reflects the strength of our partnership and our shared vision for ...

This year, a significant milestone where Scanwell Colombo has been selected to host the company’s Global Conference for the first time in Sri Lanka, solidifying its position as a regional powerhouse ...

Combining semaglutide with muscle-preserving antibodies protected lean mass – sparing approximately 50%-80% of the lean mass lost with semaglutide alone – while also increasing loss of fat mass ...

Veru's Phase 2b study shows enobosarm combined with semaglutide improves safety, reduces gastrointestinal issues, and promotes fat loss while preserving lean mass. There is a potential risk that ...

Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY ...

Phase 2b QUALITY clinical study topline safety data shows that the enobosarm + semaglutide combination had a positive safety profile compared to semaglutide alone-- --Based on Phase 2b QUALITY trial ...

What is it? A medication called semaglutide, which is sold under different brand names, including Ozempic, approved in 2017 for treating type 2 diabetes, and Wegovy, approved just last year for ...

Published in The New England Journal of Medicine on May 11, the study attempted to analyze the comparative efficacy of semaglutide (Wegovy) and tirzepatide (Zepbound) to see which drug showed better ...